熱門資訊> 正文
CervoMed announces addition to Russell 2000, Russell 3000 Indexes
2024-06-24 20:36
- CervoMed (NASDAQ:CRVO) has announced its expected addition to the Russell 2000® and 3000® Indexes, effective when the U.S. equity markets open on Monday, July 1, 2024.
- “We look forward to the further heightened awareness of our company that inclusion in the Russell Indexes may bring as we get closer to reporting topline results from the Phase 2b RewinD-LB trial in December 2024.” said John Alam, MD, CEO of CervoMed.
More on CervoMed
- CervoMed: H2 2024 Data For DLB Program A Major Inflection Point
- CervoMed GAAP EPS of -$0.82 beats by $1.23, revenue of $7.14M beats by $3.09M
- CervoMed stock soars on $149.4M private placement financing
- Historical earnings data for CervoMed
- Financial information for CervoMed
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
